Artificial neural network prediction of antisense oligodeoxynucleotide activity

Nucleic Acids Research

Volumn 30, Issue 19, 2002, Pages 4295-4304

  Giddings, Michael C ^a,c   Shah, Atul A ^a   Freier, Sue ^b   Atkins, John F ^a   Gesteland, Raymond F ^a   Matveeva, Olga V ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA;

ACCURACY; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; DATA BASE; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; IN VIVO STUDY; INTERNET; MEDICAL LITERATURE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; REVIEW; SCREENING;

EID: 0036800016     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkf557     Document Type: Review

References (28)

1. Chiang,M.Y., Chan,H., Zounes,M.A., Freier,S.M., Lima,W.F. and Bennett,C.F. (1991) Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem, 266, 18162-18171.
2. Geiger,T., Muller,M., Monia,B.P. and Fabbro,D. (1997) Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice. Clin. Cancer Res., 3, 1179-1185.
3. Jendis,J., Strack,B. and Moelling,K. (1998) Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxynucleotide TFO A. AIDS Res. Hum. Retroviruses, 14, 999-1005.
4. Gewirtz,A.M. (1999) Myb targeted therapeutics for the treatment of human malignancies. Oncogene, 18, 3056-3062.
5. Branch,A.D. (1998) A good antisense molecule is hard to find. Trends Biochem. Sci., 23, 45-50.
6. Stein,C.A. (1999) Keeping the biotechnology of antisense in context. Nat. Biotechnol., 17, 209.
7. Miraglia,L., Watt,A.T., Graham,M.J. and Crooke,S.T. (2000) Variations in mRNA content have no effect on the potency of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev., 10, 453-461.
8. Bennett,C.F., Condon,T.P., Grimm,S., Chan,H. and Chiang,M.Y. (1994) Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol., 152, 3530-3540.
9. Ho,S.P., Britton,D.H., Stone,B.A., Behrens,D.L., Leffet,L.M., Hobbs,F.W., Miller,J.A. and Trainor,G.L. (1996) Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res., 24, 1901-1907.
10. Southern,E.M., Milner,N. and Mir,K.U. (1997) Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays. Ciba Found. Symp., 209, 38-44.
11. Matveeva,O., Felden,B., Tsodikov,A., Johnston,J., Monia,B.P., Atkins,J.F., Gesteland,R.F. and Freier,S.M. (1998) Prediction of antisense oligonucleotide efficacy by in vitro methods. Nat. Biotechnol., 16, 1374-1375.
12. Stull,R.A., Taylor,L.A. and Szoka,F.C.,Jr (1992) Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices. Nucleic Acids Res., 20, 3501-3508.
13. Patzel,V., Steidl,U., Kronenwett,R., Haas,R. and Sczakiel,G. (1999) A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability. Nucleic Acids Res., 27, 4328-4334.
14. Walton,S.P., Stephanopoulos,G.N., Yarmush,M.L. and Roth,C.M. (1999) Prediction of antisense oligonucleotide binding affinity to a structured RNA target. Biotechnol. Bioeng., 65, 1-9.
15. Tu,G.C., Cao.Q.N., Zhou,F. and Israel,Y. (1999) Tetranucleotide GGGA motif in primary RNA transcripts. Novel target site for antisense design. J. Biol. Chem., 273, 25125-25131.
16. Matveeva,O.V., Tsodikov,A.D., Giddings,M., Freier,S.M., Wyatt,J.R., Spiridonov,A.N., Shabalina,S.A., Gesteland,R.F. and Atkins,J.F. (2000) Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity. Nucleic Acids Res., 28, 2862-2865.
17. Giddings,M.C., Matveeva,O.V., Atkins,J.F. and Gesteland,R.F. (2000) ODNBase-a web database for antisense oligonucleotide effectiveness studies. Bioinformatics, 16, 843-844.
18. Zell,A., Mache,N., Hubner,R., Mamier,G., Vogt,M. and Herman,K.-U. (1993) SNNS (Stuttgart Neural Network Simulator). In Skrzypek,J. (ed.), Neural Network Simulation Environments. Kluwer, Boston.
19. Solla,S., LeCun,Y. and Denker,J. (1990) Optimal Brain Damage. In Touretzky,D.S. (ed.), Advances in Neural Information Processing Systems 2. Morgan Kaufmann, San Mateo, pp. 598-605.
20. Stork,D. and Hassibi,B. (1993) Second order derivatives for network pruning: Optimal Brain Surgeon. In Hinton,G.E. and Touretzky,D.S. (eds), Advances in Neural Information Processing Systems 5. Morgan Kaufmann, San Mateo, pp. 164-171.
21. Norman,G.R. and Streiner,D.L. (1997) PDQ Statistics, 2nd Edn. Mosby, St Louis.
22. Rumelhart,D.E., Hinton,G.E. and Williams,R.J. (1986) Learning internal representations by error propagation. In Rumelhart,D.E., McClelland,J.L. and Group,P.R. (eds), Parallel Distributed Processing. MIT Press, Cambridge, MA, Vol. 1, pp. 318-364.
23. Fahlman,S.E. (1988) An Empirical Study of Learning Speed in Backpropagation Networks. Technical Report CMU-CS-88-162, Carnegie Melon University, Pittsburgh, PA.
24. Matthews,B.W. (1975) Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim. Biophys. Acta, 405, 442-451.
25. Hanley,J.A. and McNeil,B.J. (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29-36.
26. Hosmer,D.J. and Lemeshow,S. (2000) Applied Logistic Regression, 2nd Edn. John Wiley and Sons, Chichester, UK.
27. Sugimoto,N., Nakano,S., Katoh,M., Matsumura,A., Nakamuta,H., Ohmichi,T., Yoneyama,M. and Sasaki,M. (1995) Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Biochemistry, 34, 11211-11216.
28. Smith,T.F. and Waterman,M.S. (1981) Identification of common molecular subsequences. J. Mol. Biol., 147, 195-197.